Nursing diagnosis and intervention for BPAD patient with manic psychosis symptoms
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Searching the Web
nursing diagnosis NANDA bipolar disorder manic episode interventions rationale 2024
Reading Web Page
https://wtcs.pressbooks.pub/nursingmhcc/chapter/8-4-applying…
I now have comprehensive information to compile a detailed nursing care plan. Here is the complete guide:
Nursing Diagnosis and Interventions for BPAD Patient with Manic Psychosis
Bipolar Affective Disorder (BPAD) with manic psychosis combines the cardinal features of a manic episode - elevated/irritable mood, grandiosity, decreased sleep, pressured speech, racing thoughts, impulsivity - with psychotic features such as delusions and hallucinations. Nursing care must address safety, behavioral stabilization, physiological needs, and therapeutic rapport simultaneously.
Key Assessment Findings (Mental Status in Manic Psychosis)
| Domain | Findings |
|---|---|
| Appearance | Disheveled, bright or inappropriate clothing, excessive make-up |
| Behavior | Hyperactivity, restlessness, intrusive, agitated |
| Speech | Pressured, loud, rapid, flight of ideas |
| Thought content | Grandiose delusions, paranoid ideation, loose associations |
| Perception | Auditory/visual hallucinations possible |
| Affect | Euphoric, labile, irritable |
| Insight/Judgment | Severely impaired; denial of illness |
| Sleep | Markedly decreased (may feel no need for sleep) |
NANDA Nursing Diagnoses - Priority Order
1. Risk for Violence (Self-Directed or Other-Directed)
Related to: poor impulse control, irritability, psychotic thinking, impaired judgment
As evidenced by: agitation, threatening behavior, hyperactivity, verbal aggression, grandiose or paranoid delusions
Nursing Interventions and Rationale
| Intervention | Rationale |
|---|---|
| Perform continuous behavioral assessment; monitor for escalating agitation, clenched fists, raised voice, pacing | Early detection allows early de-escalation before violence occurs. Hostile verbal behaviors and poor impulse control are symptoms of acute/extreme mania |
| Maintain a calm, low-stimulation environment; remove dangerous objects (sharps, belts, cords) | Reduces environmental triggers; prevents access to means of self-harm or assault |
| Approach in a non-threatening, non-confrontational manner; use short, clear sentences | Avoids power struggles; reduces risk of reactive aggression |
| Set firm but calm behavioral limits with clear consequences; do not argue or negotiate excessively | Provides structure and predictability; arguments can escalate manic behavior |
| Alert the treatment team early if seclusion appears imminent; follow the priority sequence: verbal de-escalation → chemical restraint → seclusion | The escalation ladder ensures least-restrictive intervention first. Haloperidol + lorazepam IM is the most commonly used combination for rapid control of acute agitation |
| Administer prescribed antipsychotics (e.g., haloperidol, olanzapine, risperidone) and/or benzodiazepines (lorazepam) as ordered; monitor for respiratory depression and hypotension post-administration | Antipsychotics reduce dopamine-mediated psychomotor excitation; benzodiazepines provide rapid sedation. Combination IM therapy has fast onset - evidence supports haloperidol's efficacy within 2 days in acute mania |
| Document behavioral observations objectively at regular intervals | Legal and clinical record; supports decision-making for level of care |
2. Disturbed Thought Processes
Related to: manic psychosis, neurobiological dysregulation
As evidenced by: delusions (grandiose, paranoid), hallucinations, flight of ideas, looseness of association, poor insight
| Intervention | Rationale |
|---|---|
| Do not argue with or reinforce delusional content; acknowledge the patient's feelings without validating false beliefs ("I can see you feel very certain about that") | Arguing reinforces engagement with delusion; validating increases false belief. Therapeutic neutral stance maintains alliance |
| Re-orient to reality calmly and consistently; use simple, concrete language | Racing thoughts and loose associations impair comprehension; brief clear statements are processed more easily |
| Redirect attention to here-and-now activities when patient is preoccupied with delusional content | Behavioral redirection interrupts rumination on delusional ideas |
| Administer antipsychotic medications as prescribed; assess for efficacy and side effects (EPS, metabolic effects) | Atypical antipsychotics (risperidone, olanzapine, quetiapine, aripiprazole, cariprazine) are FDA-approved for acute mania and target dopaminergic overactivity underlying psychosis |
| Document specific content, frequency, and intensity of delusions/hallucinations | Tracks treatment response; helps identify triggers |
3. Disturbed Sleep Pattern
Related to: neurobiological changes of mania, hyperactivity, decreased need for sleep
As evidenced by: sleeping < 3 hours/night, no subjective sense of fatigue, restlessness
| Intervention | Rationale |
|---|---|
| Reinforce a minimum of 4-6 hours of sleep per night; encourage sleep during nighttime hours | Sleep deprivation perpetuates and worsens manic episodes in a self-sustaining cycle |
| Minimize stimulation in the environment at night (noise, lighting, visitors) | Reduces arousal and external triggers for continued wakefulness |
| Limit caffeine and energy drinks | Caffeine increases arousal and reduces sleep quality |
| Administer prescribed sedating agents (e.g., quetiapine, olanzapine, or benzodiazepines) at bedtime as ordered | Pharmacological sleep support breaks the mania-sleep deprivation cycle |
| Monitor total sleep time and quality; note restlessness and nocturnal wandering | Objective data for assessing improvement |
4. Imbalanced Nutrition: Less Than Body Requirements
Related to: hyperactivity, distractibility, decreased awareness of bodily needs during mania
As evidenced by: forgetting to eat, rapid weight loss, inadequate fluid intake, signs of dehydration
| Intervention | Rationale |
|---|---|
| Monitor weight, dietary intake, fluid intake, and hydration status; monitor lab results (electrolytes, BUN/creatinine) | The manic patient is unaware of bodily needs and is easily distracted; dehydration can develop rapidly |
| Offer frequent, high-calorie, high-protein snacks and drinks; provide "finger foods" that can be eaten while moving | Allows for "eating on the run" - accommodates the hyperactive state without requiring the patient to sit for meals |
| Frequently verbally remind the patient to eat and drink | Redirects attention to self-care; patient cannot self-initiate reliably |
| Limit caffeine and excessive sugar intake | Worsens agitation and hyperactivity |
| Collaborate with dietician if significant nutritional deficit present | Specialist input for tailored caloric and nutritional plan |
5. Self-Care Deficit (Hygiene, Grooming, Toileting)
Related to: hyperactivity, distractibility, impaired judgment, psychomotor agitation
As evidenced by: disheveled appearance, poor hygiene, inappropriate dress
| Intervention | Rationale |
|---|---|
| Assist with ADLs (bathing, grooming, dressing) as needed; offer reminders for basic hygiene tasks | Cognitive impairment and distractibility prevent self-initiated care |
| Provide simple, structured prompts for self-care ("Time to brush your teeth now") | Short, concrete instructions are more likely to be followed |
| Monitor for urinary/fecal urgency - patient may ignore basic signals while hyperactive | Prevents incontinence-related skin breakdown and infection |
6. Impaired Social Interaction
Related to: manic behaviors (grandiosity, intrusiveness, pressured speech), poor impulse control
As evidenced by: disruptive interactions with other patients/staff, monopolizing conversations, inappropriate sexual behavior, boundary violations
| Intervention | Rationale |
|---|---|
| Set clear, consistent, and enforceable limits on unacceptable behaviors (with all staff using the same approach) | Consistency is essential - inconsistent limit-setting allows manipulation and escalation |
| Provide structured, low-stimulation activities appropriate to current functional level | Channeled energy into purposeful activity reduces disruptive behaviors |
| Use therapeutic communication: listen, reflect, stay calm; avoid sarcasm or power struggles | Maintains therapeutic alliance while enforcing structure |
| Protect other patients from intrusive behaviors; consider single-room placement if available | Reduces conflict and protects the rights and safety of other patients |
| Reinforce appropriate social behavior promptly with positive feedback | Behavioral reinforcement strengthens desired behaviors |
7. Ineffective Coping / Non-Adherence Risk
Related to: poor insight into illness, perceived benefits of mania, distrust of medications
As evidenced by: medication refusal, denial of illness, minimizing symptoms
| Intervention | Rationale |
|---|---|
| Build a therapeutic alliance; form a working relationship before challenging beliefs | Alliance is prerequisite to influencing insight and adherence. Studies show patients often resist medication because they fear losing the "benefits" of mania |
| Provide psychoeducation in a non-judgmental way about the nature of BPAD, mood cycling, and medication purpose - when patient is in a calm or receptive state | Teaching during peak mania is ineffective; target windows of relative calm |
| Explore patient's concerns about medication (e.g., side effects, identity loss, fear of depression) | Addressing specific fears is more effective than generic education |
| Involve family/significant others in psychoeducation as appropriate | Social support is a predictor of adherence and recovery |
| Administer mood stabilizers as prescribed (lithium, valproate, carbamazepine); monitor serum levels and side effects | Mood stabilizers are the foundation of pharmacotherapy; lithium is preferred for prophylaxis and has additional anti-suicidal action. Serum level monitoring is mandatory |
8. Risk for Suicide / Self-Harm
Related to: psychotic symptoms, impulsivity, depressive swing, mixed features
As evidenced by: grandiose risk-taking behavior, poor judgment, possibility of command hallucinations
| Intervention | Rationale |
|---|---|
| Perform standardized suicide risk assessment at each shift (ideation, plan, intent, access to means) | Manic psychosis increases impulsive self-harm risk; mixed states carry particularly high suicide risk |
| Place on suicide precautions as clinically indicated; remove ligature points and harmful objects | Environmental safety is the first line of protection |
| Encourage verbal expression of feelings; validate emotional pain without reinforcing harmful intent | De-escalates internal tension; builds trust |
| Develop a safety plan collaboratively when patient is calm enough | Active involvement enhances ownership and buy-in |
| Notify the treating physician of any new or intensifying suicidal ideation | Timely escalation allows medication adjustment or level-of-care change |
Indications for Inpatient Admission
Per Kaplan & Sadock's Comprehensive Textbook of Psychiatry, indications for inpatient management include:
- Danger to self or others
- Marked psychotic symptoms
- Total inability to function
- Total loss of impulse control
- Medical conditions warranting medication monitoring (e.g., initiating lithium)
Pharmacotherapy Summary for Manic Psychosis
| Drug Class | Examples | Indication |
|---|---|---|
| Mood Stabilizers | Lithium, Valproate, Carbamazepine | Acute mania + maintenance; lithium has anti-suicidal properties |
| Atypical Antipsychotics | Olanzapine, Risperidone, Quetiapine, Aripiprazole, Cariprazine | Acute mania with psychosis; FDA-approved |
| Conventional Antipsychotics | Haloperidol, Chlorpromazine | Acute agitation; effective but higher EPS risk, risk of post-manic depression |
| Benzodiazepines | Lorazepam | Acute agitation; used with antipsychotics for IM rapid tranquilization |
Monitor baseline and ongoing: weight, waist circumference, metabolic panel, thyroid function, renal function, lithium levels, liver function (valproate), CBC (carbamazepine).
Expected Outcomes / Evaluation Criteria
- Patient remains safe; no self-harm or harm to others
- Agitation and psychomotor excitement decrease within 48-72 hours of medication
- Sleep improves to minimum 4-6 hours/night
- Adequate nutrition and hydration maintained
- Patient demonstrates beginning insight into illness and accepts treatment
- Social interactions become less intrusive; patient respects boundaries
- Delusions and hallucinations decrease in frequency and intensity
- Patient can participate in basic ADLs with prompting
Sources: Kaplan & Sadock's Comprehensive Textbook of Psychiatry; Varcarolis' Foundations of Psychiatric-Mental Health Nursing (Halter, 2022); WTCS Nursing Mental Health Concepts, Ch. 8.4; Nurseslabs Bipolar Disorder Nursing Care Plans; Fradelos et al., PMC 2024 - Nursing Care for Bipolar Disorder in Manic Episode
This is a shared conversation. Sign in to Orris to start your own chat.